Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy Meeting Abstract


Authors: Khan, S.; Lutzky, J.; Shoushtari, A. N.; Jeter, J. M.; Chiuzan, C.; Sender, N.; Blumberg, L. E.; Nesson, A.; Singh-Kandah, S. V.; Hernandez, S.; Ambrosini, G.; Surriga, O.; Schwartz, G. K.; Carvajal, R. D.
Abstract Title: Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy
Meeting Title: 56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 15 Suppl.
Meeting Dates: 2020 May 29-31
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-05-20
Start Page: 520s
Language: English
ACCESSION: WOS:000560368300178
PROVIDER: wos
DOI: 10.1200/JCO.2020.38.15_suppl.10075
Notes: Meeting Abstract: 10075 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors